U.S. R&D Spending Keeps Pharmaceutical Sector at the Forefront of Global Drug Development
The United States continues to dominate global pharmaceutical and biotechnology drug development, underpinned by record levels of research and development (R&D) investment and a steady flow of regulatory approvals. Data for 2023 and 2024 show that U.S. companies committed more than $104 billion to R&D in 2024 alone, accounting for 55 percent of worldwide biopharmaceutical […]